Cargando…

Comparison of the Performance of 24 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in the Diagnosis of Coronavirus Disease 2019 Patients

BACKGROUND: The accurate detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the key to control Coronavirus Disease-2019 (COVID-19). The performance of different antibody detection methods for diagnosis of COVID-19 is inconclusive. METHODS: Between 16 February and 28 Februar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Shiji, Hou, Hongyan, Li, Huijun, Wang, Ting, Wei, Wei, Zhang, Minxia, Yin, Botao, Huang, Min, Sun, Ziyong, Wang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393512/ https://www.ncbi.nlm.nih.gov/pubmed/36003928 http://dx.doi.org/10.3389/fmicb.2022.876227

Ejemplares similares

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)

The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes
por: Tang, Guoxing, et al.
Publicado: (2021)

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients
por: Choi, Hyun-Woo, et al.
Publicado: (2022)

Editorial: Advances in emerging coronavirus identification and tracing methods
por: Peng, Junping, et al.
Publicado: (2023)

Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)

Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
por: Salazar-García, Marcela, et al.
Publicado: (2022)

Coronavirus Disease 2019: Clinics, Treatment, and Prevention
por: Burkert, Francesco Robert, et al.
Publicado: (2021)

Characteristics and Prognosis of Antibody Non-responders With Coronavirus Disease 2019
por: Ding, Junyu, et al.
Publicado: (2022)

Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019
por: Dai, Jiayu, et al.
Publicado: (2022)

Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus
por: Zheng, Yu-Zhong, et al.
Publicado: (2021)

A rapid colloidal gold immunochromatographic assay for the diagnosis of coronavirus disease 2019
por: Wang, Xiao-Ling, et al.
Publicado: (2020)

Respiratory care for the critical patients with 2019 novel coronavirus
por: Wang, Yao-Chen, et al.
Publicado: (2021)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus
por: Chen, Zhi-Min, et al.
Publicado: (2020)

Respiratory infections in Coronavirus disease 2019
por: del Pozo, Jose L.
Publicado: (2022)

Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19)
por: Lu, Yong, et al.
Publicado: (2020)

Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Mutation Hotspots Associated With Clinical Outcomes and Transmission
por: Pang, Xianwu, et al.
Publicado: (2021)

Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells
por: Chu, Hin, et al.
Publicado: (2018)

Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019
por: Luo, Ying, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
por: Pulvirenti, Federica, et al.
Publicado: (2021)

An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
por: Devaux, Christian A., et al.
Publicado: (2022)

HLA-DR Expression Level in CD8(+) T Cells Correlates With the Severity of Children With Acute Infectious Mononucleosis
por: Wang, Yun, et al.
Publicado: (2021)

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
por: Ai, Tao, et al.
Publicado: (2020)

Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?
por: Weiskirchen, Ralf
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
por: Wu, Jun, et al.
Publicado: (2020)

Implications of LDH in patients with coronavirus disease 2019 pneumonia
por: Mu, Tong, et al.
Publicado: (2023)

Middle East Respiratory Syndrome Coronavirus and the One Health concept
por: Hemida, Maged Gomaa
Publicado: (2019)

Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019
por: Zhao, Hong-Mei, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
por: Chen, I-Yin, et al.
Publicado: (2019)

Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study
por: Chen, Liting, et al.
Publicado: (2021)

Insights Into the Changing Landscape of Coronavirus Disease 2019
por: Escobedo, Ruby A., et al.
Publicado: (2022)

Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen
por: Yamaoka, Yutaro, et al.
Publicado: (2016)

Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2
por: Wang, Ting, et al.
Publicado: (2022)

Microbial and human transcriptional profiling of coronavirus disease 2019 patients: Potential predictors of disease severity
por: Gan, Hairun, et al.
Publicado: (2022)

Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus
por: Wu, Kailang, et al.
Publicado: (2012)

Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
por: Tuli, Hardeep Singh, et al.
Publicado: (2021)

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
por: Wang, Wen-Xin, et al.
Publicado: (2022)

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus
por: Bi, Jinhao, et al.
Publicado: (2022)

Coronavirus disease 2019 antibody testing in pregnancy
por: Zullo, Fabrizio, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus-2 IgG antibody response to coronavirus disease 2019 vaccination in South Indian health-care professionals with and without coronavirus disease 2019 exposure
por: Jayashri, Ramamoorthy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_82fkj9qcd8bdi9m1supmd44hal